Skip Navigation

We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker |  Email Alerts

Yoon-Young Jang, M.D., Ph.D.

Headshot of Yoon-Young Jang
  • Co-Director, Stem Cell Biology Laboratory
  • Associate Professor of Oncology

Background

Titles

  • Co-Director, Stem Cell Biology Laboratory
  • Associate Professor of Oncology

Departments / Divisions

  • Oncology - Cancer Genetics and Epigenetics

Centers & Institutes

Education

Degrees

  • M.D.; Chung Ang University - Seoul (South Korea) (1998)
  • Ph.D.; Chung Ang University - Seoul (South Korea) (2002)

Additional Training

  • Johns Hopkins Medical Institutions, Baltimore, MD, 2004, Postdoctoral training

Research & Publications

Selected Publications

View all on PubMed

  1. Chaudhari P, Ye Z, Jang YY. Roles of reactive oxygen species in the fate of stem cells. Antioxid Redox Signal. 2014 Apr 20;20(12):1881-90. doi: 10.1089/ars.2012.4963. Epub 2012 Nov 19. PMID: 23066813 [PubMed - in process]
  2. Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, Liu JO, Deng C, Ye Z, Jang YY. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology. 2013 Jun;57(6):2458-68. doi: 10.1002/hep.26237.
    PMID: 23325555
  3. Sharkis SJ, Jones RJ, Civin C, Jang YY. Pluripotent stem cell-based cancer therapy: promise and challenges. Sci Transl Med. 2012 Mar 28;4(127):127ps9. doi: 10.1126/scitranslmed.3003920. Review. PMID: 22461639 
  4. Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, Feller-Kopman D, Yarmus LB, Lin YC, Welm AL, Issa JP, Minn I, Matsui W, Jang YY, Sharkis SJ, Baylin SB, Zahnow CA. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell. 2012 Mar 20;21(3):430-46. doi: 10.1016/j.ccr.2011.12.029. PMID: 22439938 
  5. Ye Z, Liu CF, Jang YY. Hematopoietic cells as sources for patient-specific iPSCs and disease modeling. Cell Cycle. 2011 Sep 1;10(17):2840-4. Epub 2011 Sep 1. PMID: 21857158

Contact for Research Inquiries

Email me
Is this you? Edit Profile
back to top button